A phase II study of gemcitabine and oxaliplatin (Oxigem) in unresectable gall bladder cancer.
Sharma A, Mohanti B, Raina V, Shukla N, Pal S, Dwary A, Deo S, Sahni P, Garg P, Thulkar S, DattaGupta S, Rath G.
Sharma A, et al.
Cancer Chemother Pharmacol. 2010 Feb;65(3):497-502. doi: 10.1007/s00280-009-1055-0. Epub 2009 Jul 3.
Cancer Chemother Pharmacol. 2010.
PMID: 19575200
Clinical Trial.